[1]JournalofMedicinalChemistry,2013,vol.56,#9,p.3478-3491
[1]BioorganicandMedicinalChemistry,1997,vol.5,#8,p.1675-1683
[1]BioorganicandMedicinalChemistry,1997,vol.5,#8,p.1675-1683
[1]BioorganicandMedicinalChemistry,1997,vol.5,#8,p.1675-1683
[1]BioorganicandMedicinalChemistry,1997,vol.5,#8,p.1675-1683
[1]CurrentPatentAssignee:M'SSCIENCECORPORATION-WO2007/21545,2007,A2Locationinpatent:Page/Pagecolumn17-18
Title: Matsuno K, et al. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist. Eur J Pharmacol. 1996 Jun 13;306(1-3):271-9.
Title: Minabe Y, et al. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study. Synapse. 1999 Aug;33(2):129-40.
Title: Ono Y, et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett. 2014 Jan 24;559:174-8.
